Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III Trial of Surgery Followed by Conventional RT(5fr/Week)Vs.Concurrent Chemo-Radiotherapy Vs.Accelerated RT(6fr/Week)in High Risk, Loco-Regionally Advanced, Stage III&IVA, Resectable, Squamous Cell Carcinomas of Oralcavity

NCT00193843 is registered in ClinicalTrials.gov with Tata Memorial Hospital as lead sponsor.

NCT NCT00193843
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00193843 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III Trial of Surgery Followed by Conventional RT(5fr/Week)Vs.Concurrent Chemo-Radiotherapy Vs.Accelerated RT(6fr/Week)in High Risk, Loco-Regionally Advanced, Stage III&IVA, Resectable, Squamous Cell Carcinomas of Oralcavity
Lead sponsor
Tata Memorial Hospital
Phase
Phase 3
Overall status
Unknown status
Start date
June 30, 2005
Completion date
June 30, 2017
Enrollment
900
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

mouth neoplasms